← Open Payments lookup

AKEEM BOROM: Open Payments

NPI 1316679822 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,733 in 163 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $3,166 · 2025 $3,733

Food & beverage: $3,733
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc14$584
Neurocrine BioSciences, Inc.17$556
ABBVIE INC.19$447
E.R. Squibb & Sons, L.L.C.16$351
Alkermes, Inc.11$274
Otsuka America Pharmaceutical, Inc.12$271
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$231
Teva Pharmaceuticals USA, Inc.13$231
Lundbeck LLC14$207
Vanda Pharmaceuticals Inc.11$201

Products named: INGREZZA, VRAYLAR, SPRAVATO, REXULTI, COBENFY, ARISTADA, CAPLYTA, FANAPT.

Industry payments across CA — which companies pay providers there.